Of four frontrunners in the race for a vaccine for COVID-19 – Moderna, Pfizer and BioNTech, Inovio Pharmaceuticals, and AstraZeneca – is there any indication at this point whose vaccine candidate is the most promising – and thus which biotech may be the best buy for investors? Indeed, growing evidence regarding antibodies and the SARS-CoV-2 virus may point to a best vaccine bet. For more, CLICK HERE.
Which Frontrunner’s COVID-19 Vaccine Candidate May Hold The Most Promise – And Why?
- by Bob Mitchell